Rimegepant
Artikelen filtered by tag "rimegepant"
The following articles contain the tag rimegepant:
New drug: lasmiditan for migraine attacks
Two new drugs for the acute treatment of migraine attacks were authorised in 2022. They concern the ‘calcitonin gene-related peptide’ (CGRP) antagonist rimegepant, which was previously discussed in Ge-Bu, and the 5HT1F agonist lasmiditan. New age ...
New drug: rimegepant for migraine attacks
Two million people in the Netherlands regularly experience migraine. In addition to preventive medication, a large proportion of patients also use drugs for the acute treatment of a migraine attack. The cornerstone of this therapy are the triptan ...
